Red Queen borne by Apple Tree Partners

Life sciences venture capital company Apple Tree Partners (ATP) has unveiled Red Queen Therapeutics, a biotech developing antivirals for the general population and especially for immunocompromised patients at increased risk of serious illness or death from common and emerging viral pathogens.

Red Queen is co-founded by ATP and Loren Walensky, professor of pediatrics at Harvard Medical School, principal investigator and attending physician in the Department of Pediatric Oncology at the Dana-Farber Cancer Institute/Boston Children’s Hospital, and Director of the Harvard/MIT MD-PhD Program.